Summary of the Clinical Practice Guidelines for Male Infertility by the Japanese Urological Association With the Support of the Japan Society for Reproductive Medicine
International Journal of Urology · 2025
DOI: 10.1111/iju.70132 ↗Kurz gefasst
Leitlinie in der Zeitschrift International Journal of Urology, 2025. Verfasst von Akira Tsujimura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Juntendo University Urayasu Hospital, Urayasu, Japan. Hauptthemen laut MEDLINE: Infertility, Male, Reproductive Medicine. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 73 Literaturangaben.
Abstract (Originalsprache)
These 2024 guidelines address male infertility amid Japan's declining birth rate, following the recent provision of national health insurance coverage for infertility treatments. Male factors contribute to approximately 50% of infertility cases, with spermatogenic dysfunction being the most common cause (82.4%). The guidelines provide evidence‐based recommendations for diagnosing and treating male infertility. Diagnostic approaches include comprehensive medical history, physical examination, semen analysis, hormone testing, genetic testing for severe cases, and appropriate imaging studies. Treatment recommendations cover both medical and surgical interventions. Medical treatments include gonadotropin therapy for hypogonadotropic hypogonadism (grade A), clomiphene citrate for oligozoospermia with low testosterone (grade B), and antioxidant therapy (limited evidence: grade C). Surgical treatments focus on varicocelectomy for palpable varicoceles (grade A), with microsurgical approaches preferred. Nonobstructive azoospermia is treated by microdissection testicular sperm extraction (micro‐TESE) (grade A). The guidelines also emphasize preserving fertility before cancer treatment, managing sexual dysfunction with PDE5 inhibitors (grade A), and treating retrograde ejaculation with tricyclic antidepressants (grade B).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Juntendo University Urayasu Hospital, Urayasu, Japan.
- Department of Urology, Kanazawa Municipal Hospital, Kanazawa, Japan.
- Department of Urology, Nagoya City University West Medical Center, Nagoya, Japan.
- Department of Urology, Toho University Omori Medical Center, Tokyo, Japan.
- Department of Urology, Kameda Medical Center, Kamogawa, Japan.
- Department of Urology, Yamaguchi University Graduate School of Medicine, Ube, Japan.
ORCID-Profile: Akira Tsujimura, Koji Shiraishi, Shinichiro Fukuhara, Yasushi Yumura
Zitieren
APA
Tsujimura, A., Iijima, M., Umemoto, Y., Kobayashi, H., Komiya, A., Shiraishi, K., Chiba, K., Hirota, Y., Fukuhara, S., & Yumura, Y. (2025). Summary of the Clinical Practice Guidelines for Male Infertility by the Japanese Urological Association With the Support of the Japan Society for Reproductive Medicine. International Journal of Urology. https://doi.org/10.1111/iju.70132
Vancouver
Tsujimura A, Iijima M, Umemoto Y, Kobayashi H, Komiya A, Shiraishi K, et al. Summary of the Clinical Practice Guidelines for Male Infertility by the Japanese Urological Association With the Support of the Japan Society for Reproductive Medicine. International Journal of Urology. 2025. doi:10.1111/iju.70132
BibTeX
@article{Tsujimura2025,
author = {Tsujimura, Akira and Iijima, Masashi and Umemoto, Yukihiro and Kobayashi, Hideyuki and Komiya, Akira and Shiraishi, Koji and Chiba, Koji and Hirota, Yasushi and Fukuhara, Shinichiro and Yumura, Yasushi},
title = {Summary of the Clinical Practice Guidelines for Male Infertility by the Japanese Urological Association With the Support of the Japan Society for Reproductive Medicine},
journal = {International Journal of Urology},
year = {2025},
doi = {10.1111/iju.70132}
}
EUVIMED